1. MCLA-129, a human anti-EGFR and anti-c-MET bispecific antibody, in patients with advanced NSCLC and other solid tumors: an ongoing phase 1/2 study. (October 2022) Authors: Ou, S.H.; Moreno Garcia, V.; Gil Bazo, I.; Prenen, H.; Moreno, I.; Johnson, M.; Castañón Álvarez, E.; Nagasaka, M.; Adeyemi, S.; Barasa, B.; Bol, K.; Doze, P.; Engbers, A.; Joe, A.K.; Stalbovskaya, V.; Laus, G.; Call, J. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PO-0805 Analysis of esophageal cancer patients treated with neoadjuvant therapy who never made it to surgery. (April 2019) Authors: Thomas, M.; Depypere, L.; Moons, J.; Coosemans, W.; Lerut, T.; Prenen, H.; Haustermans, K.; Van Veer, H.; Nafteux, P. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S418 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗